Article Details

Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated ...

Retrieved on: 2021-05-13 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated .... View article details on hiswai:

Excerpt

Amgen and AstraZeneca hope the focus on severe asthma, and the specific cytokine that tezepelumab targets, will help them carve out a piece of the ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up